Haemato AG buy Covacoro
Start price
11.01.16
/
50%
€48.68
Target price
19.12.16
€60.00
Performance (%)
35.15%
End price
19.12.16
€62.79
Summary
This prediction ended on 19.12.16 with a price of €62.79. With a performance of 35.15% the BUY prediction by Covacoro was a big success. Covacoro has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Haemato AG | - | - | - | - |
iShares Core DAX® | -1.215% | 4.788% | 16.604% | 15.523% |
iShares Nasdaq 100 | -1.911% | 1.109% | 19.364% | 31.093% |
iShares Nikkei 225® | -3.171% | 5.626% | 10.519% | 1.800% |
iShares S&P 500 | -1.029% | 1.792% | 20.514% | 35.443% |
According to Covacoro what are the pros and cons of Haemato AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cons
Comments by Covacoro for this prediction
In the thread Haemato AG diskutieren
Haemato - profitabel, parallel, pfiffig
- gute Q3-Zahlen und ausgezeichnete Q4-Zahlen
- guter Ausblick auf 2016
- Wachstum voraus
Wer mehr Details lesen will, findet sie hier
http://www.covacoro.de/2016/01/11/haemato-profitabel-parallel-pfiffig/
(Zielkurs erreicht)
Stopped prediction by Covacoro for Haemato AG
Haemato AG
Start price
Target price
Perf. (%)
€28.90
02.05.21
02.05.21
€35.00
02.05.22
02.05.22
-4.50%
15.05.21
15.05.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model